A morphogenetic regulatory role for ethyl alcohol in Candida albicans

Mycoses

Volumn 54, Issue 6, 2011, Pages

  Chauhan, Nitin M ^a   Raut, Jayant S ^a   Karuppayil, S Mohan ^a  

^a SWAMI RAMANAND TEERTH MARATHWADA UNIVERSITY   (India)

Author keywords

Candida biofilm; Ethyl alcohol; Morphogenesis; Signal transduction

Indexed keywords

ALCOHOL; POLYSTYRENE; SILICONE;

ARTICLE; BIOFILM; CANDIDA ALBICANS; CELL ELONGATION; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; FUNGAL CELL; FUNGAL DEVELOPMENT; GERM LAYER; GROWTH INHIBITION; GROWTH REGULATION; IC 50; MORPHOGENESIS; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE;

BIOFILMS; CANDIDA ALBICANS; ENVIRONMENTAL MICROBIOLOGY; ETHANOL; GENE EXPRESSION REGULATION, FUNGAL; HUMANS; MICROBIAL VIABILITY; POLYSTYRENES; SILICON;

CANDIDA; CANDIDA ALBICANS;

EID: 80054007142     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2010.02002.x     Document Type: Article

References (38)

1. Soll DR, Lockhart SR, Zhao R. Relationship between switching and mating in Candida albicans. Eukaryot Cell 2003; 02: 390-7.
2. Fidel PL, Vazquez JA, Sobel DA. Candida glabarata: review of epidemiology, pathogenesis and clinical disease with comparison to Candida albicans. Clin Microbiol Rev 1999; 12: 80-96.
3. Odds FC. Candida species and virulence. ASM News 1994; 60: 313-8.
4. Dupont B, Denning DW, Marriott D, Sugar A, Viviani MA, Sirisanthana T. Mycoses in AIDS patients. J Med Vet Mycol 1994; 32: 65-77.
5. Coleman DC, Bennett DE, Sulvian DJ et al. Oral Candida in HIV infection and AIDS: new perspective/new approach. Cri Rev Microbiol 1993; 19: 61-82.
6. Walsh TJ. Invasive fungal infections: problem and challenges for developing new antifungal compounds. In: Sutcliffe J, Gergopapadakou NH (eds), Emerging Targets in Antibacterial and Antifungal Chemotherapy. New York: Chapman and Hall, 1992: 349-73.
7. Gow NA. Germ tube growth of Candida albicans. Curr Top Med Mycol 1997; 8: 43-55.
8. Cutler JE. Putative virulence factors of Candida albicans. Ann Rev Microbiol 1991; 45: 187-218.
9. Saville SP, Lazzell AL, Monteagudo C, Lopez-Ribot JL. Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot Cell 2003; 02: 1053-60.
10. Lo HJ, Kohler JR, DiDomenico B, Loebenberg D, Cacciapuoti A, Fink GR. Nonfilamentous Candida albicans mutants are avirulent. Cell 1997; 90: 939-49.
11. Noble SM, French S, Kohn LA, Chen V, Johnson AD. Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenecity. Nat Gen 2010; 42: 590-8.
12. Davis-Hanna A, Piispanen AE, Stateva LI, Hogan DA. Farnesol and dodecanol effects on the Candida albicans Ras 1-cAMP signaling pathway and the regulation of morphogenesis. Mol Biol 2008; 67: 47-62.
13. Chen H, Fink GR. Feedback control of morphogenesis in fungi by aromatic alcohols. Genes Dev 2006; 20: 1150-61.
14. Nickerson KW, Atkin AL, Hornby JM. Quorum sensing in dimorphic fungi: farnesol and Beyond. Appl Environ Microbiol 2006; 72: 3805-13.
15. Mosel DD, Dumitru R, Hornby JM, Atkin AL, Nickerson KW. Farnesol concentrations required to block germ tube formation in the presence and absence of serum. Appl Environ Microbiol 2005; 71: 4938-40.
16. Dickinson JR. Filamentation formation in Saccharomyces cerevisiae- a review. Folia Microbiol 2008; 53: 3-14.
17. Martins M, Henriques M, Azeredo J, Rocha SM, Coimbra MA, Oliveira R. Morphogenesis control in Candida albicans and Candida dubliniensis through signaling molecules produced by planktonic and biofilm cells. Eukaryot Cell 2007; 06: 2429-36.
18. Ogaswara A, Odhara K, Toume M, Watanabe T, Mikami T, Matsumoto T. Change in the respiration system of Candida albicans in the lag and log growth phase. Biol Pharm Bull 2006; 29: 448-50.
19. Land GA, McDonald WC, Stjernholm RL, Friedman L. Factors affecting filamentation in Candida albicans: changes in the respiratory activity of Candida albicans during filamentation. Infect Immun 1975; 12: 119-27.
20. Smith MG, Etages SG, Synder M. Microbial synergy via an ethyl alcohol-triggered pathway. Mol Cellular Biol 2004; 24: 3874-84.
21. Pollack JH, Hashimoto T. Ethyl alcohol contamination in commercial buffers: ethyl alcohol contaminating Tris-malate and other commercial buffers induces germ tube formation in Candida albicans. Appl Environ Microbiol 1984; 48: 1051-2.
22. Bell WM, Chaffin WL. Effect of yeast growth conditions on yeast-mycelial transition in Candida albicans. Mycopathologia 1983; 84: 41-44.
23. Chiew YY, Sullivan PA, Sheperd MG. The effects of ergosterol and alcohols on germ-tube formation and chitin synthatase in Candida albicans. Can J Biochem 1982; 60: 15-20.
24. Mukherjee PK, Mohamed S, Chandra J et al. Alcohol dehydrogenase restricts the ability of pathogen Candida albicans to form a biofilm on catheter surfaces through an ethyl alcohol-based mechanism. Infect Immun 2006; 74: 3804-16.
25. Maharaj AR, Zelenitsky SA, Vercaigne LM. Effect of ethyl alcohol/trisodium citrate hemodialysis catheter locking solution on isolates of Candida albicans. Hemodial Int 2008; 14: 10-14.
26. Nett JE, Guite KM, Ringeisen A, Holoyda KA, Andes DR. Reduced biocide susceptibility in Candida albicans biofilms. Antimicrob Agents Chemother 2008; 52: 3411-3.
27. Hudson DB, Sciascia QL, Sanders JA et al. Identification of dialyzable serum inducer of germ-tube formation in Candida albicans. Microbiology 2004; 150: 3041-9.
28. Aneja KR. Micrometry. In: Experiments in Microbiology, Plant Pathology and Biotechnology, 4th edn. New Delhi, India: New Age International, 2003: 60-65.
29. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast. Approved standard NCCLS M27-A. Wayne, PA: National Committee for Clinical Laboratory Standards, 1997.
30. Westwater C, Balish E, Schofield DA. Candida albicans-conditioned medium protects yeast cells from oxidative stress: a possible link between quorum sensing and oxidative stress resistance. Eukaryot Cell 2005; 10: 1654-61.
31. Chandra JD, Kuhn M, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. Biofilm formation by the fungal pathogen Candida albicans: development, architecture & drug resistance. J Bacteriol 2001; 183: 5385-94.
32. Peeter E, Nelis HJ, Coenye T. Comparision of multiple methods for quantification of microbial biofilms grown in microtitre plates. Microbiol. Methods 2007; 72: 157-65.
33. Bozzola JJ, Russell LD. Electron Microscopy Principles and Techniques for Biologists, 2nd edn. Sudbury, MA: Jones and Barlett Publishers, 1998: 19-67.
34. Martinez-Anaya C, Dickinson JR, Sudbery PE. In yeast, the pseudohyphal phenotype induced by isoamyl alcohol results from the operation of the morphogenesis check point. J Cell Science 2003; 116: 3423-31.
35. Dumitru R, Hornby JN, Nickerson KW. Defined anaerobic growth medium for studying Candida albicans basic biology and resistance to eight antifungal drugs. Antimicrob Agents Chemother 2004; 48: 2350-4.
36. Piskur J, Rozpedowska E, Polakova S, Merico A, Compagno C. How did Saccharomyces evolve to become a good brewer? Trends Genet 2006; 22: 183-6.
37. Siew-Ying Lim C, Wong W, Rosli R, Kee-Peng N, Seow H, Chong P. 2-dodecanol (decyl methyl carbinol) inhibits hyphal formation and SIR 2 expression in C. albicans. J Basic Microbiol 2009; 49: 579-83.
38. Kebaara BW, Langford ML, Dhammika HM et al. Candida albicans Tup 1 is involved in Farnesol-mediated inhibition of filamentous-growth inhibition. Eukaryot Cell 2008; 7: 980-7.